Trial · NCT07907081
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Serum Low-density lipoprotein (LDL) cholesterol concentration (milligrams per deciliter) | Baseline and 30 days | LDL was measured according to enzymatic reactions in serum or plasma by using Hitachi 704 analyzer serviced by Roche diagnostics |
| Primary | Serum High-density lipoprotein (HDL) cholesterol concentration (milligrams per deciliter) | Baseline and 30 days | HDL was measured according to enzymatic reactions in serum or plasma by using Hitachi 704 analyzer serviced by Roche diagnostics |
| Primary | Serum Very low-density lipoprotein (VLDL) cholesterol concentration (milligrams per deciliter) | Baseline and 30 days | VLDL was measured according to enzymatic reactions in serum or plasma by using Hitachi 704 analyzer serviced by Roche diagnostics |
| Primary | Serum total cholesterol concentration (milligrams per deciliter) | Baseline and 30 days | Total cholesterol was measured according to enzymatic reactions in serum or plasma by using Hitachi 704 analyzer serviced by Roche diagnostics. |
| Primary | Serum triglycerides concentration (milligrams per deciliter) | Baseline and 30 days | Triglycerides were measured according to enzymatic reactions in serum or plasma by using Hitachi 704 analyzer serviced by Roche diagnostics |
| Secondary | Fasting Blood Glucose concentration (milligrams per deciliter) | Baseline and 30 days | Fasting Blood Glucose was measured by using enzymatic method in Roche Modular P chemistry analyzer |
| Secondary | Serum alanine aminotransferase (ALT) concentration (milligrams per deciliter) | Baseline and 30 days | ALT was measured by using Hitachi 704 analyzer serviced by Roche diagnostics |
| Secondary | Serum aspartate aminotransferase (AST) concentration (milligrams per deciliter) | Baseline and 30 days | AST was measured by using Hitachi 704 analyzer serviced by Roche diagnostics |
| Secondary | Serum alkaline phosphatase (ALP) concentration (milligrams per deciliter) | Baseline and 30 days | ALP was measured by using Hitachi 704 analyzer serviced by Roche diagnostics |
| Secondary | Serum bilirubin concentration (milligrams per deciliter) | Baseline and 30 days | Bilirubin was measured by using Hitachi 704 analyzer serviced by Roche diagnostics |
| Secondary | Serum urea concentration (milligrams per deciliter) | Baseline and 30 days | Urea was analyzed with refrigerated serum in Beckman Synchron LX20 |
| Secondary | Serum creatinine concentration (milligrams per deciliter) | Baseline and 30 days | Creatinine was analyzed with refrigerated serum in Beckman Synchron LX20 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07907081/registered